Page last updated: 2024-10-22

am 251 and Hypertension

am 251 has been researched along with Hypertension in 9 studies

AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.

Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.

Research Excerpts

ExcerptRelevanceReference
"These results broadly support the literature showing that the cardiovascular effects of cannabinoids can be exaggerated in hypertension, but highlight the involvement of non-CB(1) receptor-mediated mechanisms in the actions of anandamide."3.75Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats. ( Gardiner, SM; Ho, WS, 2009)
"We conclude that endocannabinoids tonically suppress cardiac contractility in hypertension and that enhancing the CB1-mediated cardiodepressor and vasodilator effects of endogenous anandamide by blocking its hydrolysis can normalize blood pressure."3.72Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. ( Bátkai, S; Bukoski, RD; Harvey-White, J; Kunos, G; Liu, J; Mackie, K; Offertáler, L; Osei-Hyiaman, D; Pacher, P; Radaeva, S; Rudd, MA, 2004)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (55.56)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, GQ2
Wang, Z1
Zhao, T1
Dai, SX1
Liu, JM1
Jia, BZ1
Zhang, Y2
Li, Q2
Wang, T1
Zhang, HP1
Ho, WS1
Gardiner, SM4
Szekeres, M1
Nádasy, GL1
Turu, G1
Soltész-Katona, E1
Tóth, ZE1
Balla, A1
Catt, KJ1
Hunyady, L1
Iring, A1
Ruisanchez, É1
Leszl-Ishiguro, M1
Horváth, B1
Benkő, R1
Lacza, Z1
Járai, Z1
Sándor, P1
Di Marzo, V1
Pacher, P2
Benyó, Z1
Bátkai, S1
Osei-Hyiaman, D1
Radaeva, S1
Liu, J1
Harvey-White, J1
Offertáler, L1
Mackie, K1
Rudd, MA1
Bukoski, RD1
Kunos, G1
Wheal, AJ2
Bennett, T2
Randall, MD3
O'Sullivan, SE1

Other Studies

9 other studies available for am 251 and Hypertension

ArticleYear
Role of cannabinoid receptor type 1 in rostral ventrolateral medulla in high-fat diet-induced hypertension in rats.
    Journal of hypertension, 2018, Volume: 36, Issue:4

    Topics: Animals; Blood Pressure; Diet, High-Fat; Endocannabinoids; Gene Silencing; Heart Rate; Hypertension;

2018
Overactivation of cannabinoid receptor type 1 in rostral ventrolateral medulla promotes cardiovascular responses in spontaneously hypertensive rats.
    Journal of hypertension, 2017, Volume: 35, Issue:3

    Topics: Animals; Arachidonic Acids; beta-Arrestin 2; Blood Pressure; Essential Hypertension; Heart Rate; Hyp

2017
Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.
    British journal of pharmacology, 2009, Volume: 156, Issue:1

    Topics: Acute Disease; Amidohydrolases; Animals; Arachidonic Acids; Benzamides; Benzoxazines; Blood Pressure

2009
Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors.
    The Journal of biological chemistry, 2012, Sep-07, Volume: 287, Issue:37

    Topics: Analgesics; Angiotensin II; Animals; Arteries; Benzoxazines; Endocannabinoids; Endothelium, Vascular

2012
Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation.
    PloS one, 2013, Volume: 8, Issue:1

    Topics: Animals; Arachidonic Acids; Arterial Pressure; Cerebrovascular Circulation; Endocannabinoids; Heart

2013
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.
    Circulation, 2004, Oct-05, Volume: 110, Issue:14

    Topics: Amidohydrolases; Angiotensin II; Animals; Arachidonic Acids; Benzamides; Benzyl Compounds; Blood Pre

2004
Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro.
    British journal of pharmacology, 2007, Volume: 150, Issue:5

    Topics: Animals; Arachidonic Acids; Benzoxazines; Blood Pressure; Cannabinoids; Disease Models, Animal; Dose

2007
The in vitro and in vivo cardiovascular effects of Delta9-tetrahydrocannabinol in rats made hypertensive by chronic inhibition of nitric-oxide synthase.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 321, Issue:2

    Topics: Animals; Blood Pressure; Dronabinol; Enzyme Inhibitors; Heart Rate; Hypertension; Male; NG-Nitroargi

2007
Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats.
    British journal of pharmacology, 2007, Volume: 152, Issue:5

    Topics: Animals; Arachidonic Acids; Benzoxazines; Blood Pressure; Cannabinoids; Cardiovascular System; Consc

2007